TherapeuticsMD (TXMD) Ending Cash Balance (2009 - 2026)
TherapeuticsMD (TXMD) recorded Ending Cash Balance of $9.19 million in Q2 2026, up 51.4% from $6.07 million a year earlier and up 9.1% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, TherapeuticsMD reported Ending Cash Balance of $7.48 million, up 47.9% from FY2024.
- Annual Ending Cash Balance has a five-year compound annual growth rate of -37.8% (FY2020 to FY2025).
- Across earlier years, Ending Cash Balance came in at $5.06 million in FY2024 (+16.9%), $4.33 million in FY2023 (-91.2%), $49.32 million in FY2022 (-24.0%) and $64.91 million in FY2021 (-19.4%).
- The Q2 2026 figure is the highest quarterly Ending Cash Balance since Q3 2023.
- On a year-over-year basis, Ending Cash Balance has increased for three consecutive quarters, with growth averaging 39.0% over the last five quarters.
- Peak year-over-year performance for Ending Cash Balance in the last five years was growth of 51.4% in Q2 2026, against a decline of 91.2% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - | 9.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.19 Mn |
| Mar 31, 2026 | 8.42 Mn |
| Dec 31, 2025 | 7.48 Mn |
| Sep 30, 2025 | 7.12 Mn |
| Jun 30, 2025 | 6.07 Mn |
| Mar 31, 2025 | 5.75 Mn |
| Dec 31, 2024 | 5.06 Mn |
| Sep 30, 2024 | 5.05 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Mar 31, 2024 | 4.34 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Sep 30, 2023 | 49.32 Mn |
| Jun 30, 2023 | 49.32 Mn |
| Mar 31, 2023 | 17.25 Mn |
| Dec 31, 2022 | 49.32 Mn |
| Sep 30, 2022 | 65.12 Mn |
| Jun 30, 2022 | 65.12 Mn |
| Mar 31, 2022 | 65.12 Mn |
| Dec 31, 2021 | 64.91 Mn |
| Sep 30, 2021 | 104.84 Mn |
API Access
TherapeuticsMD Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();